
001
TenTherma® has officially welcomed the important milestone of breaking through 250 installations across Taiwan. This not only represents the continuous expansion of the brand in the Taiwanese market, but also symbolizes the recognition of equipment quality and clinical application by more and more medical institutions.
To commemorate this milestone, Weiju has specially launched the "TenTherma Installation 250 Units Milestone - Taiwan Tour Documentary", visiting partner clinics in the North, Central, and South of Taiwan to share this honor with physician partners, and to record the important moments of the brand's journey.
▲
Weiju visited partner clinics across Taiwan to celebrate surpassing 250 installations of tenera throughout the country.
002
In this tour documentary, the image of brand ambassador Kai Ko accompanied the tour vehicle all across Taiwan, becoming one of the highlights of the journey.
As the tour vehicle traveled to various places, many people also happened to spot the Tenthera tour vehicle printed with Kai Ko's image on the streets. This tour not only conveyed the brand's joy of surpassing 250 installed units, but also allowed more people to understand Tenthera's brand journey of continuous market cultivation and steady growth.
▲
TenThera's brand ambassador Kai Ko takes the promotional roadshow truck across Taiwan to celebrate and share the milestone of device installations.
003
Surpassing 250 units is just a new starting point. In the future, Weiju will officially launch the "Dual-Wave Strategy," continuing to integrate brand resources and clinical application advantages as we join hands with our physician partners to welcome the next stage of development.
From equipment introduction and education training to clinical exchanges, Weiju will continue to accompany our partners, jointly promoting the continuous advancement of medical beauty technology, moving toward the next pinnacle five years, and creating more memorable milestones.
▲
Tixel has achieved a milestone of over 250 installations across Taiwan, joining hands with physician partners to embark on the next phase of development.








































